- Home
- NAOV vs ACON Comparison
NAOV vs ACON Comparison
Compare NAOV & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAOV
- ACON
- Stock Information
- Founded
- NAOV 2003
- ACON 2008
- Country
- NAOV United States
- ACON United States
- Employees
- NAOV N/A
- ACON N/A
- Industry
- NAOV Industrial Specialties
- ACON Retail: Computer Software & Peripheral Equipment
- Sector
- NAOV Health Care
- ACON Technology
- Exchange
- NAOV Nasdaq
- ACON Nasdaq
- Market Cap
- NAOV 1.5M
- ACON 1.7M
- IPO Year
- NAOV N/A
- ACON 2022
- Fundamental
- Price
- NAOV $0.66
- ACON $0.17
- Analyst Decision
- NAOV
- ACON Strong Buy
- Analyst Count
- NAOV 0
- ACON 1
- Target Price
- NAOV N/A
- ACON $1.50
- AVG Volume (30 Days)
- NAOV 234.5K
- ACON 748.9K
- Earning Date
- NAOV 11-14-2024
- ACON 11-14-2024
- Dividend Yield
- NAOV N/A
- ACON N/A
- EPS Growth
- NAOV N/A
- ACON N/A
- EPS
- NAOV N/A
- ACON N/A
- Revenue
- NAOV $3,291,000.00
- ACON $49,289.00
- Revenue This Year
- NAOV N/A
- ACON N/A
- Revenue Next Year
- NAOV N/A
- ACON $256.16
- P/E Ratio
- NAOV N/A
- ACON N/A
- Revenue Growth
- NAOV 227.79
- ACON N/A
- 52 Week Low
- NAOV $0.46
- ACON $0.16
- 52 Week High
- NAOV $1.55
- ACON $7.39
- Technical
- Relative Strength Index (RSI)
- NAOV 56.05
- ACON 41.09
- Support Level
- NAOV $0.62
- ACON $0.16
- Resistance Level
- NAOV $0.74
- ACON $0.21
- Average True Range (ATR)
- NAOV 0.05
- ACON 0.02
- MACD
- NAOV 0.01
- ACON -0.00
- Stochastic Oscillator
- NAOV 66.16
- ACON 10.42
About NAOV NanoVibronix Inc.
NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products are UroShield; PainShield; and WoundShield. Each of its UroShield, PainShield, and WoundShield products employs a small, disposable transducer that transmits low-frequency, low-intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. The company derives revenues from selling its products directly to patients as well as through distributor agreements.
About ACON Aclarion Inc.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The Company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.